Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019)
Allogene Therapeutics (ALLO) posted Tax Rate of 0.21% for Q4 2019, down 55.68% sequentially from 0.48% in Q2 2019, and down 17.0% YoY from 0.26% in Q4 2018.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Tax Rate (2018 - 2019) Analysis & Trends
Allogene Therapeutics has reported Tax Rate for 2 years, with the latest figure at 0.21% in Q4 2019.
- Quarterly Tax Rate fell 17.0% year-over-year to 0.21% in Q4 2019, while the trailing twelve-month figure through Sep 2020 was 0.05% (down 18.0% YoY) and the FY2024 annual result came in at 0.17%, changed N/A from the prior year.
- Tax Rate fell to 0.21% in Q4 2019 per ALLO's latest filing, from 0.48% in the prior quarter.
- Over five years, Tax Rate peaked at 0.48% in Q2 2019 and troughed at 0.16% in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Allogene Therapeutics | 647.99 Mn | 647.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 0.21% |
| Sep 30, 2019 | -0.07% |
| Jun 30, 2019 | 0.48% |
| Mar 31, 2019 | 0.32% |
| Dec 31, 2018 | 0.38% |